These medications are transforming the treatment landscape, dramatically improving the amount of weight loss achievable through medication alone or in combination with lifestyle interventions, shared Miranda Stiewig-Rapp, assistant professor of endocrinology at UC Davis Health
Chronic diseases such as diabetes, obesity, hypertension, heart disease have a link to metabolic dysfunction
Using the zebrafish lateral line to understand the roles of mitochondria in sensorineural hearing loss
Curiously, LEADER revealed a downward trend in hospitalization rates for heart failure (-13%, P = 0.14) [4]
The post hoc analysis of pooled data from the Semaglutide Treatment Effect in People with Obesity (STEP) 1, 2, 3, and 5 trials indicated that semaglutide treatment at 2.4 mg did not increase the risk of depressive symptoms or suicidal ideation compared to placebo, while demonstrating a statistically significant yet clinically negligible decrease in depressive symptoms [75]
Oct 1998;68(4):899-917